Stay updated on Open-Label Surufatinib in EU NET Patients Clinical Trial

Sign up to get notified when there's something new on the Open-Label Surufatinib in EU NET Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Open-Label Surufatinib in EU NET Patients Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A site-wide notice announces that NIH is transitioning to the term “Super Intelligence” in place of “Artificial Intelligence.” The site revision changed from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T19:06:10.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer now identifies the ClinicalTrials.gov release as v3.7.1 instead of v3.7.0; the study record still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T18:16:34.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study record content with an error notice. This indicates restricted access to the trial information that users expect on this page.
    Difference
    17%
    Check dated 2026-09-22T22:24:33.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.7.0, replacing the previous Revision: v3.6.6. This indicates a backend or documentation update behind the page while the study details remain unchanged.
    Difference
    0.1%
    Check dated 2026-09-15T20:22:18.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6. No study content or data on the page appears to have changed.
    Difference
    0.1%
    Check dated 2026-09-01T18:05:04.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.4 to v3.6.5. This reflects a maintenance update to the page.
    Difference
    0.0%
    Check dated 2026-08-11T08:43:37.000Z thumbnail image

Stay in the know with updates to Open-Label Surufatinib in EU NET Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Open-Label Surufatinib in EU NET Patients Clinical Trial page.